A study reveals that low-dose inorganic nanoparticles can promote liver health by combating fatty liver disease, offering a potential new approach to metabolic disorder treatments. Background — Targeting Fatty Liver…

A novel in vivo self-assembly strategy has emerged as a game-changing approach to enhancing ferroptosis-based cancer therapy, achieving significant tumor suppression while addressing delivery challenges of current treatments. Ferroptosis: A…

The emergence of mRNA-based therapies has revolutionized the fight against COVID-19, particularly in response to the challenges posed by the highly transmissible Omicron variant. Since the onset of the pandemic…

Urease-powered nanobots have shown remarkable potential in the treatment of bladder cancer, achieving a substantial reduction in tumor size. Bladder Cancer — Current Challenges Bladder cancer is a common and…

The Evolution of Theranostic Agents: A Historical Perspective The development of theranostic agents, which seamlessly integrate diagnostics and therapeutics, has transformed cancer treatment. Initially, these agents relied heavily on conventional…

A bacteria-responsive hydrogel with self-activating antibacterial properties offers a promising solution for accelerating the healing of infected wounds. Background Infected wounds, particularly those associated with chronic bacterial infections, present significant…

Introduction: Decoding Tumor Evasion Strategies Cancer cells have developed sophisticated mechanisms to evade the immune system, allowing them to proliferate unchecked. One prominent strategy is the overexpression of CD47, a…

Background Diabetic osteoporosis (DOP) is a severe complication of diabetes that weakens bones, increasing the risk of fractures and other skeletal issues. Despite its prevalence, effective treatments for DOP remain…